Immatics Us, Inc. competitive analysis

Explore Immatics Us, Inc.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Oct 15, 2025Methods For Activating, Modifying And Expanding Gamma Delta T Cells For The Treatment Of Cancer And Related Malignancies1
Aug 28, 2024Sorting With Counter Selection Using Sequence Similar Peptides1

Latest PTAB cases involving Immatics Us, Inc.

Discover the latest PTAB cases involving Immatics Us, Inc., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Immatics Us, Inc. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IMMATICS - 2 - -
MILTENYI BIOTEC54 - -
STRAWMAN468 - - -